Halifax-based 3D BioFibR Inc., only formed in July, has closed a $550,000 funding round that will launch its mission to produce commercial quantities of nature’s “strongest, lightest and toughest” materials.
The equity round – believed to be the first by an Atlantic Canadian company founded since the pandemic started – includes $150,000 from Concrete Ventures and $100,000 from Innovacorp.
The company is already distinguished by its co-founders. CEO Kevin Sullivan is a veteran of several life sciences companies and most recently founded Appili Therapeutics, leading it through its listing on
